NCT05308719View on ClinicalTrials.gov

Nasal Oxygen Therapy After Cardiac Surgery

NACompletedINTERVENTIONAL
Enrollment

1,280

Participants

Timeline

Start Date

September 8, 2020

Primary Completion Date

December 6, 2024

Study Completion Date

December 6, 2024

Conditions
Cardiac Valve DiseaseCoronary Artery DiseaseRespiratory Failure
Interventions
DEVICE

High Flow Nasal Therapy

High Flow Nasal Oxygen (Airvo2 Device)

Trial Locations (1)

CB20AY

Royal Papworth Hospital NHS Foundation Trust, Cambridge

All Listed Sponsors
collaborator

University Hospitals, Leicester

OTHER

collaborator

King's College London

OTHER

lead

Papworth Hospital NHS Foundation Trust

OTHER_GOV

NCT05308719 - Nasal Oxygen Therapy After Cardiac Surgery | Biotech Hunter | Biotech Hunter